Patents by Inventor Zachary H. Shriver

Zachary H. Shriver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9709567
    Abstract: The present invention provides HA polypeptides (e.g., H1 HA polypeptides) that bind to umbrella-topology glycans, and reagents and methods relating thereto. The present invention provides binding agents that bind to HA polypeptides (e.g., H1 HA polypeptides), and reagents and methods relating thereto. The present invention provides interfering agents that inhibit the binding of HA polypeptides (e.g., H1 HA polypeptides) to HA receptors, and reagents and methods relating thereto. The present invention provides compositions and methods for treating, preventing, and/or diagnosing influenza infection utilizing HA polypeptides, HA polypeptide binding agents, HA polypeptide interfering agents, and/or vaccine compositions comprising any of the foregoing.
    Type: Grant
    Filed: January 28, 2016
    Date of Patent: July 18, 2017
    Assignee: Massachusetts Institute of Technology
    Inventors: Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Zachary H. Shriver, Ram Sasisekharan
  • Publication number: 20160266117
    Abstract: The present invention provides HA polypeptides (e.g., H1 HA polypeptides) that bind to umbrella-topology glycans, and reagents and methods relating thereto. The present invention provides binding agents that bind to HA polypeptides (e.g., H1 HA polypeptides), and reagents and methods relating thereto. The present invention provides interfering agents that inhibit the binding of HA polypeptides (e.g., H1 HA polypeptides) to HA receptors, and reagents and methods relating thereto. The present invention provides compositions and methods for treating, preventing, and/or diagnosing influenza infection utilizing HA polypeptides, HA polypeptide binding agents, HA polypeptide interfering agents, and/or vaccine compositions comprising any of the foregoing.
    Type: Application
    Filed: January 28, 2016
    Publication date: September 15, 2016
    Inventors: Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Zachary H. Shriver, Ram Sasisekharan
  • Patent number: 9278998
    Abstract: The present invention provides HA polypeptides (e.g., H1 HA polypeptides) that bind to umbrella-topology glycans, and reagents and methods relating thereto. The present invention provides binding agents that bind to HA polypeptides (e.g., H1 HA polypeptides), and reagents and methods relating thereto. The present invention provides interfering agents that inhibit the binding of HA polypeptides (e.g., H1 HA polypeptides) to HA receptors, and reagents and methods relating thereto. The present invention provides compositions and methods for treating, preventing, and/or diagnosing influenza infection utilizing HA polypeptides, HA polypeptide binding agents, HA polypeptide interfering agents, and/or vaccine compositions comprising any of the foregoing.
    Type: Grant
    Filed: July 2, 2010
    Date of Patent: March 8, 2016
    Assignee: Massachusetts Institute of Technology
    Inventors: Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Zachary H. Shriver, Ram Sasisekharan
  • Publication number: 20110033490
    Abstract: The present invention provides HA polypeptides (e.g., H1 HA polypeptides) that bind to umbrella-topology glycans, and reagents and methods relating thereto. The present invention provides binding agents that bind to HA polypeptides (e.g., H1 HA polypeptides), and reagents and methods relating thereto. The present invention provides interfering agents that inhibit the binding of HA polypeptides (e.g., H1 HA polypeptides) to HA receptors, and reagents and methods relating thereto. The present invention provides compositions and methods for treating, preventing, and/or diagnosing influenza infection utilizing HA polypeptides, HA polypeptide binding agents, HA polypeptide interfering agents, and/or vaccine compositions comprising any of the foregoing.
    Type: Application
    Filed: July 2, 2010
    Publication date: February 10, 2011
    Applicant: Massachusetts Institute of Technology
    Inventors: Akila Jayaraman, Karthik Viswanathan, Rahul Raman, Zachary H. Shriver, Ram Sasisekharan